Connected technology continues to advance, with the market for the internet of things in healthcare valued at $100.41 billion in 2022 and projected to reach $495.47 billion by 2030. In the clinical trials arena, these technologies can ease information sharing, simplify study conduct, and ultimately improve patient experiences.
For patients and physicians alike, clinical research provides hope that ongoing innovation will offer new options to treat and even cure challenging illnesses. Indeed, most of modern medicine revolves around learnings from disruptive, successful clinical trials that investigated the safety and efficacy of promising therapeutic options.
Social justice models can contribute to diversity, equity and inclusion (DE&I) in clinical trials and across companies, helping to ensure a fair and equitable division of resources, access and opportunities.
While many sites have not yet transitioned away from the traditional paper-based source model for data, electronic source may represent an efficient systematic alternative to this traditional method.
Transformation in the life sciences sector are being driven by the adoption of artificial intelligence, machine learning, and natural language processing, and by the exploitation of “big data” sources in new and powerful ways.